Close Menu

NEW YORK — Shuwen Biotech said on Tuesday that it has received CE-IVD marking for its SARS-COV-2 RT-PCR Kit.

The test is designed to detect the SARS-CoV-2 ORF1ab and N genes in upper and lower respiratory specimens including nasal, nasopharyngeal and oropharyngeal swabs, Shuwen said. It has been validated on many widely available RT-PCR instruments including Thermo Fisher Scientific's Applied Biosystems 7500 and 7500 Fast systems, Roche's Cobas Z480 and LightCycler 480II, Bio-Rad Laboratories' CFX96, and Qiagen's Rotor-Gene Q.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

The Financial Times reports the US bolstering its ability to track SARS-CoV-2 alterations.

The New York Times reports that Cedars-Sinai researchers have uncovered a new strain of SARS-CoV-2 in Southern California.

In Nucleic Acids Research this week: pan-cancer atlas focus on miRNA biogenesis mutations, methylation analysis of pig skeletal muscles, and more.

President-elect Joe Biden has nominated Eric Lander to serve as director of the Office of Science and Technology Policy, the Associated Press says.

Sponsored by
Foundation Medicine

In this session, the first in the Precision Oncology News Virtual Molecular Tumor Board Series, our expert panelists will review patient cases in which genomic profiling has identified biomarkers related to homologous recombination deficiency and DNA damage repair.

Sponsored by

Host immune responses play a central role in controlling SARS-CoV-2 infection, but they remain incompletely characterized and understood.

Sponsored by

The composition of the immune infiltrate in the human tumor microenvironment is a critical determinant of disease progression. 

Sponsored by
Thermo Fisher Scientific

As the world continues to contend with coronavirus and a surge in the infection rate, labs are required to run more samples than ever before.